The Healthcare Venture Operating System.
Power more connected, data-driven experiences by bringing together STEM education, clinical partnerships, and venture capital. Unify your entire institute on one platform.
Past Cohorts
Track B · Incubator
Fall 2026 Cohort
Founders
Completion
Milestone
Curriculum Progress
Live Session: FDA Strategy
Dr. Sarah Jenkins · Starting in 5 mins
Trailblazing institutions put IGVP at the center of the constituent experience.
Experience the Healthcare Venture Operating System
Watch how IGVP seamlessly unifies STEM education, clinical trial acceleration, and venture capital portfolio management on a single enterprise platform.
Live Sourcing
Real-time venture deal flow
STEM Cloud
CME-accredited learning
Agentforce AI
510(k) regulatory copilot
Vetted LP OS
Automated LP reporting
One Ecosystem. Many Pathways.
Select your path and explore programs, communities, and opportunities built specifically for you.
Students
Get venture-ready while you study. Build. Learn. Lead.
Founders
Build globally scalable healthcare companies.
Upskilling Professionals
Advance your career with venture and business skills.
Rising Investors
Learn. Invest. Grow with the next generation.
Partners
Collaborate with institutions and expand impact.
Service Providers
Support founders. Grow your business.
Investors
Access curated deal flow and co-invest.
IGVP STEM Learning Portal
CME Accredited · Live Cohort Workspace
Bio-Design & FDA 510(k) Clearance Masterclass
IGVP AI Tutor Response:
Predetermined Change Control Plans (PCCP) allow AI models to update post-clearance without new 510(k) filings.
14 Credits
CME Accredited
4.9 / 5.0 ★
Learner Rating
1,240+
Clinicians Enrolled
STEM & Clinical Education Platform
Deliver CME-accredited tracks, cohort-based learning, and personalized AI tutors designed specifically for clinicians, researchers, and technical founders scaling healthcare solutions. Maximize staff impact institution-wide.
IGVP Venture Capital OS
Portfolio Intelligence & Deal Room
NeuroGen Bio Inc.
Series A · $14.0M Round
Cardia AI Diagnostics
Seed Sprint · $3.5M Round
Venture Capital Operating System
Manage your entire healthcare portfolio in one place. Automate deal flow tracking, streamline investment committee memos, and generate real-time LP reporting seamlessly integrated with your CRM.
Agentforce™ Copilot Suite
Autonomous Healthcare Venture Agents
Automated 510(k) Pre-Submission draft generated for Cardia-AI.
Investment memo risk score evaluated: 0.12 (Low Risk).
Paired Johns Hopkins Cardiologist with Stanford BME Fellow for Sprint #08.
Agentforce: AI Copilot Suite
Engage prospective founders and deliver instant, personalized support. Use our FDA regulatory assistant, pitch coach, grant writer, and intelligent founder-matching agents to scale your operations 24/7.
The Platform
One operating system.
Every role, every workflow.
Portfolio
Round Size
Committed
Investors
Close ETA
Fundraising Velocity
$8.4M / $12M
Investor Pipeline
IGVP AI · Investment memo drafted
Based on 14 investor conversations & clinical milestones · 2 min ago
Where Healthtech Leaders & Venture Capital Converge.
Participate in CME-accredited webinars, exclusive LP deal-room summits, FDA regulatory workshops, and bio-design pitch sprints.
IGVP Global Bio-Innovation & Healthtech Summit 2026
Connecting 500+ Bio-Founders, FDA Regulators, Health System CMOs & Tier-1 VCs
Agenda Highlights
Keynote & VC Panelists
Dr., Elena, Prof., Dr. + 20 more
Summit Date
OCT 14 - 16, 2026
9:00 AM - 5:00 PM EST
Already registered for the summit?
IGVP Global Bio-Innovation & Healthtech Summit 2026
The annual flagship gathering bringing together leaders across STEM, clinical medicine, regulatory affairs, and venture capital. Includes 1-on-1 VC speed dating and live FDA regulatory Q&A.
Featured Speakers
Dr. Sarah Jenkins
VP of Regulatory · Genentech
Elena Kowalski
General Partner · Emerald VC
Prof. Marcus Vance
Director of Bio-Design · Stanford
Dr. Aris Thorne
Chief Innovation Officer · Mayo Clinic
FDA 510(k) AI/ML Software Clearance Masterclass
Learn how to navigate SaMD (Software as a Medical Device) submissions, Good Machine Learning Practice (GMLP), and risk management standards under ISO 14971.
Featured Speakers
Dr. Aris Thorne
Former FDA Reviewer · Mayo Clinic
Maya Lin
Regulatory Counsel · IGVP OS
Fall 2026 Bio-Incubator Demo Day & Syndicate Summit
Exclusive deal-room session featuring Track B Incubator cohort graduates with lab-validated IP, FDA clearance roadmaps, and signed health system LOIs.
Featured Speakers
David Chen
Managing Director · Nexus Capital
Dr. Priya Ravindran
Founder & CEO · NeuroGen Bio
Lab-to-Market Delaware Flip & IP Commercialization
A practical tactical workshop covering spinout licensing agreements, founder equity splits, Delaware C-Corp flips, and avoiding cap table debt during early angel rounds.
Featured Speakers
Marcus Okafor, MD
Co-Founder · Cardia Health
Jonathan Vance
Partner · BioTech Legal Group
Clinical Trial Site Matching & EHR Data Pipeline Integration
Explore clinical trial acceleration techniques, IRB approval templates, and synthetic patient dataset usage for training medical AI diagnostic models.
Featured Speakers
Dr. Sarah Jenkins
Chief Medical Officer · Cardia Health
Prof. Marcus Vance
Director of Bio-Design · Stanford Medicine
Digital Health Reimbursement & CPT Coding Strategy 2027
Deep dive into securing Category I & III CPT codes, commercial payer contracting, and demonstrating economic value ROI for hospital procurement committees.
Featured Speakers
Elena Kowalski
General Partner · Emerald VC
Dr. Aris Thorne
Former CMS Policy Advisor · Mayo Clinic
Success Stories
Ventures born inside IGVP.
"IGVP compressed five years of trial-and-error into one cohort. We closed our Series A ninety days after Demo Day."
Dr. Priya Ravindran
Founder & CEO · NeuroGen Bio
$14M SERIES A
"The only place where I could pitch to a Kaiser CMO on Monday and an a16z partner on Wednesday — in one workspace."
Marcus Okafor, MD
Co-founder · Cardia Health
3 HOSPITAL LOIS
"As an investor, IGVP deal flow is pre-vetted, pre-diligenced and pre-clinical-validated. Our conversion tripled."
Elena Kowalski
Partner · Emerald Health Ventures
12 INVESTMENTS
"We gained unparalleled access to clinical advisors who helped us navigate FDA hurdles in record time."
Sarah Jenkins
CTO · MedTech Solutions
FDA CLEARED
"The platform is our source of truth for all LP communications. It's transformed how we raise and deploy capital."
David Chen
Managing Director · Nexus Capital
FUND II CLOSED
"IGVP compressed five years of trial-and-error into one cohort. We closed our Series A ninety days after Demo Day."
Dr. Priya Ravindran
Founder & CEO · NeuroGen Bio
$14M SERIES A
"The only place where I could pitch to a Kaiser CMO on Monday and an a16z partner on Wednesday — in one workspace."
Marcus Okafor, MD
Co-founder · Cardia Health
3 HOSPITAL LOIS
"As an investor, IGVP deal flow is pre-vetted, pre-diligenced and pre-clinical-validated. Our conversion tripled."
Elena Kowalski
Partner · Emerald Health Ventures
12 INVESTMENTS
"We gained unparalleled access to clinical advisors who helped us navigate FDA hurdles in record time."
Sarah Jenkins
CTO · MedTech Solutions
FDA CLEARED
"The platform is our source of truth for all LP communications. It's transformed how we raise and deploy capital."
David Chen
Managing Director · Nexus Capital
FUND II CLOSED